首页 > 最新文献

Annals of Thoracic Surgery最新文献

英文 中文
Synchronous Primary Lung Cancer: Sequence of Therapy and Tumor Biology. 同步原发性肺癌:治疗序列和肿瘤生物学。
IF 3.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-31 DOI: 10.1016/j.athoracsur.2025.12.015
Whitney S Brandt
{"title":"Synchronous Primary Lung Cancer: Sequence of Therapy and Tumor Biology.","authors":"Whitney S Brandt","doi":"10.1016/j.athoracsur.2025.12.015","DOIUrl":"https://doi.org/10.1016/j.athoracsur.2025.12.015","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145893346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mentorship, Sponsorship, and Beyond-Additional Considerations for Women in Cardiothoracic Surgery. 指导、赞助和超越——女性心胸外科手术的额外考虑。
IF 3.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-31 DOI: 10.1016/j.athoracsur.2025.12.020
Nicole M Mott, Elizabeth A David
{"title":"Mentorship, Sponsorship, and Beyond-Additional Considerations for Women in Cardiothoracic Surgery.","authors":"Nicole M Mott, Elizabeth A David","doi":"10.1016/j.athoracsur.2025.12.020","DOIUrl":"https://doi.org/10.1016/j.athoracsur.2025.12.020","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145893311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Thoracic Surgery Directors Association In-Training Exam: Development, Implementation, and Six-Year Trends. 胸外科主任协会在职考试:发展、实施和六年趋势。
IF 3.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-31 DOI: 10.1016/j.athoracsur.2025.12.008
Cherie P Erkmen, Aitua Salami, Anastasiia K Tompkins, Ravi Ghanta, Matthew Romano, Aundrea Oliver, Panos Vardas, Richard D Mainwaring, Kirsten Freeman, Sara Periera, Adam Doty, Ahmet Kilic, Stephen Yang, David T Cooke

Background: The Thoracic Surgery Directors Association In-Training Exam (TSITE) provides an annual, formative standardized assessment for cardiothoracic surgery trainees. This report outlines its historical development, governance, administration, and performance data from exams delivered from 2020 to 2025.

Methods: The TSITE is administered annually by the Thoracic Surgery Directors Association to assess trainee knowledge using a structured taxonomy aligned with American Board of Thoracic Surgery (ABTS) qualification content. The multiple-choice question exam comprises 160 questions (80 cardiac, 80 thoracic) derived through a rigorous question-writing and vetting process. Annual metrics included exam completion time, average scores, performance distribution, and Cronbach alpha.

Results: Examinee numbers increased from 437 in 2020 to 567 in 2025. Cronbach alpha ranged from 0.80 to 0.86, reflecting high reliability. A shift from four options, with three distractors to three options and two distractors in 2025 decreased average exam time. Score distributions demonstrated stable performance trends, with most trainees scoring between 50% and 69%.

Conclusions: The TSITE is a valid, reliable, and evolving personalized learning tool that supports both trainee self-assessment and programmatic benchmarking. Its iterative refinement reflects ongoing efforts to align with evolving clinical practice, ABTS expectations, and user feedback.

背景:胸外科主任协会培训考试(TSITE)为心胸外科培训生提供年度形成性标准化评估。本报告概述了其历史发展、治理、管理和2020年至2025年考试的绩效数据。方法:TSITE由胸外科主任协会每年进行一次,使用与美国胸外科委员会(ABTS)资格内容一致的结构化分类来评估受训人员的知识。多项选择题考试包括160个问题(80个心脏问题,80个胸外科问题),这些问题是通过严格的写作和审查过程得出的。年度指标包括考试完成时间、平均分数、表现分布和Cronbach alpha。结果:考生人数从2020年的437人增加到2025年的567人。Cronbach alpha在0.80 ~ 0.86之间,具有较高的信度。到2025年,从4个选项加3个干扰物到3个选项加2个干扰物的转变减少了平均考试时间。得分分布表现出稳定的表现趋势,大多数学员的得分在50%到69%之间。结论:TSITE是一种有效的、可靠的、不断发展的个性化学习工具,它既支持学员自我评估,也支持程序性基准测试。它的迭代改进反映了与不断发展的临床实践、ABTS期望和用户反馈保持一致的持续努力。
{"title":"The Thoracic Surgery Directors Association In-Training Exam: Development, Implementation, and Six-Year Trends.","authors":"Cherie P Erkmen, Aitua Salami, Anastasiia K Tompkins, Ravi Ghanta, Matthew Romano, Aundrea Oliver, Panos Vardas, Richard D Mainwaring, Kirsten Freeman, Sara Periera, Adam Doty, Ahmet Kilic, Stephen Yang, David T Cooke","doi":"10.1016/j.athoracsur.2025.12.008","DOIUrl":"https://doi.org/10.1016/j.athoracsur.2025.12.008","url":null,"abstract":"<p><strong>Background: </strong>The Thoracic Surgery Directors Association In-Training Exam (TSITE) provides an annual, formative standardized assessment for cardiothoracic surgery trainees. This report outlines its historical development, governance, administration, and performance data from exams delivered from 2020 to 2025.</p><p><strong>Methods: </strong>The TSITE is administered annually by the Thoracic Surgery Directors Association to assess trainee knowledge using a structured taxonomy aligned with American Board of Thoracic Surgery (ABTS) qualification content. The multiple-choice question exam comprises 160 questions (80 cardiac, 80 thoracic) derived through a rigorous question-writing and vetting process. Annual metrics included exam completion time, average scores, performance distribution, and Cronbach alpha.</p><p><strong>Results: </strong>Examinee numbers increased from 437 in 2020 to 567 in 2025. Cronbach alpha ranged from 0.80 to 0.86, reflecting high reliability. A shift from four options, with three distractors to three options and two distractors in 2025 decreased average exam time. Score distributions demonstrated stable performance trends, with most trainees scoring between 50% and 69%.</p><p><strong>Conclusions: </strong>The TSITE is a valid, reliable, and evolving personalized learning tool that supports both trainee self-assessment and programmatic benchmarking. Its iterative refinement reflects ongoing efforts to align with evolving clinical practice, ABTS expectations, and user feedback.</p>","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145893349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distinct Subgroups and Outcomes in Patients with Hypertrophic Obstructive Cardiomyopathy After Septal Myectomy. 中隔肌切除术后肥厚性梗阻性心肌病患者的不同亚组和预后。
IF 3.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-31 DOI: 10.1016/j.athoracsur.2025.12.009
Siyu Zhang, Qiuchen Yuan, Zitian Zhu, Long Deng, Hao Nie, Tao Liang, Xin Wang

Background: Hypertrophic obstructive cardiomyopathy (HOCM) is a structurally heterogeneous disease with variable clinical outcomes. While septal myectomy provides symptomatic benefits, interindividual differences in postoperative risk and long-term prognosis remain unknown.

Methods: A retrospective cohort of 699 patients with HOCM was analyzed. A Latent class analysis model was derived to identify distinct subgroups. Group-specific postoperative and long-term outcomes were compared. A decision tree model was developed to simplify clinical classification.

Results: Three subgroups were identified: Group 1 (younger patients), Group 2 (older patients with smaller left atrial diameter [LAD]), and Group 3 (older patients with enlarged LAD). Compared with Group 1, Group 3 had a significantly higher risk of postoperative new-onset atrial fibrillation, prolonged ventilation, renal failure, and composite complications During a median follow-up of 7.7 years, Group 3 showed an increased risk of composite outcome of all-cause mortality and cardiac readmission (adjusted hazard ratio, 1.67; 95% CI, 1.13-2.45, P = 0.009) and major adverse cardiac and cerebrovascular events (adjusted hazard ratio, 2.18; 95% CI, 1.17-4.05; P = 0.014). Group 1 had the highest risk of ventricular arrhythmias compared with Group 2 (adjusted hazard ratio, 2.58; 95% CI, 1.20-5.57; P = 0.016). A simplified decision tree using age ≥ 50 years and LAD ≥ 42 mm achieved a classification accuracy of 95.7%.

Conclusions: Latent class analysis revealed distinct subgroups of HOCM. Older patients with enlarged LAD portended the highest cardiovascular risk, while younger patients had elevated arrhythmia risk. Subgroup-based stratification may inform personalized perioperative and long-term surveillance strategies in HOCM patients.

背景:肥厚性梗阻性心肌病(HOCM)是一种结构异质性疾病,临床结果多变。虽然鼻中隔切除术提供了症状上的益处,但术后风险和长期预后的个体差异仍然未知。方法:对699例HOCM患者进行回顾性队列分析。一个潜在类分析模型被导出来识别不同的亚群。组间术后和远期预后比较。建立决策树模型以简化临床分类。结果:分为3个亚组:1组(年轻患者),2组(左房内径较小的老年患者[LAD]), 3组(左房内径增大的老年患者)。与1组相比,3组术后新发房颤、延长通气时间、肾功能衰竭和复合并发症的风险显著增加。在中位随访7.7年期间,3组的全因死亡率和心脏再入院(校正风险比为1.67;95% CI为1.13-2.45,P = 0.009)和主要心脑血管不良事件(校正风险比为2.18;95% CI为1.17-4.05;P = 0.014)的复合结局风险增加。与组2相比,组1发生室性心律失常的风险最高(校正风险比为2.58;95% CI为1.20-5.57;P = 0.016)。年龄≥50岁、LAD≥42 mm的简化决策树分类准确率达到95.7%。结论:潜在分类分析显示HOCM有不同的亚群。LAD增大的老年患者心血管风险最高,而年轻患者心律失常风险升高。基于亚组的分层可以为HOCM患者提供个性化的围手术期和长期监测策略。
{"title":"Distinct Subgroups and Outcomes in Patients with Hypertrophic Obstructive Cardiomyopathy After Septal Myectomy.","authors":"Siyu Zhang, Qiuchen Yuan, Zitian Zhu, Long Deng, Hao Nie, Tao Liang, Xin Wang","doi":"10.1016/j.athoracsur.2025.12.009","DOIUrl":"https://doi.org/10.1016/j.athoracsur.2025.12.009","url":null,"abstract":"<p><strong>Background: </strong>Hypertrophic obstructive cardiomyopathy (HOCM) is a structurally heterogeneous disease with variable clinical outcomes. While septal myectomy provides symptomatic benefits, interindividual differences in postoperative risk and long-term prognosis remain unknown.</p><p><strong>Methods: </strong>A retrospective cohort of 699 patients with HOCM was analyzed. A Latent class analysis model was derived to identify distinct subgroups. Group-specific postoperative and long-term outcomes were compared. A decision tree model was developed to simplify clinical classification.</p><p><strong>Results: </strong>Three subgroups were identified: Group 1 (younger patients), Group 2 (older patients with smaller left atrial diameter [LAD]), and Group 3 (older patients with enlarged LAD). Compared with Group 1, Group 3 had a significantly higher risk of postoperative new-onset atrial fibrillation, prolonged ventilation, renal failure, and composite complications During a median follow-up of 7.7 years, Group 3 showed an increased risk of composite outcome of all-cause mortality and cardiac readmission (adjusted hazard ratio, 1.67; 95% CI, 1.13-2.45, P = 0.009) and major adverse cardiac and cerebrovascular events (adjusted hazard ratio, 2.18; 95% CI, 1.17-4.05; P = 0.014). Group 1 had the highest risk of ventricular arrhythmias compared with Group 2 (adjusted hazard ratio, 2.58; 95% CI, 1.20-5.57; P = 0.016). A simplified decision tree using age ≥ 50 years and LAD ≥ 42 mm achieved a classification accuracy of 95.7%.</p><p><strong>Conclusions: </strong>Latent class analysis revealed distinct subgroups of HOCM. Older patients with enlarged LAD portended the highest cardiovascular risk, while younger patients had elevated arrhythmia risk. Subgroup-based stratification may inform personalized perioperative and long-term surveillance strategies in HOCM patients.</p>","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145893151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tracheobronchial Membrane Tapering Resection for Tracheobronchomalacia with Wide Posterior Membrane. 气管支气管膜渐窄切除术治疗后膜宽的气管支气管软化症。
IF 3.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-31 DOI: 10.1016/j.athoracsur.2025.12.010
C Jason Smithers, Hester F Shieh, Shawn Izadi, Farokh R Demehri, Somala Mohammed, Russell W Jennings, Benjamin Zendejas

Background: Tracheobronchomalacia is characterized by excessive dynamic airway collapse, often associated with a wide posterior membrane. We report outcomes of an innovative tapering membrane reduction tracheobronchoplasty (TMRT) designed to narrow the posterior membrane and improve functional airway stability.

Methods: Retrospective study of patients who underwent TMRT for severe tracheobronchomalacia with wide posterior membrane from 2022-2024 at two institutions. Under bronchoscopic guidance, a longitudinal strip of posterior membrane was resected with concurrent two-layered longitudinal closure. Patient characteristics and outcomes were analyzed.

Results: Eighty-five patients (male 65%; esophageal atresia 66%) underwent TMRT at median age of 30 months (range newborn-21 years). Common indications included recurrent respiratory infections (41%), inability to wean from positive pressure ventilation (21%) and blue spells (18%) . Tapered segment was tracheal (68%), bronchial (5%), and both (27%). Concomitant procedures included posterior tracheobronchopexy (96%), posterior descending aortopexy (7%), and esophageal repair (35%). Median follow was 22 (interquartile range 18-26) months. Significant improvements were seen in blue spells, respiratory infections and ability to wean from ventilation or supplemental oxygen (p<0.05). Complications included esophageal leak (4%), transient vocal fold dysfunction (7%), chylothorax (4%), dysphagia requiring esophageal dilation (8%), and tracheal stenosis requiring dilation (1%). Four patients (5%) required subsequent airway procedures. There were no mortalities.

Conclusions: TMRT is feasible and safe for severe tracheobronchomalacia with a wide posterior membrane and is associated with substantial early improvement in functional airway stability and respiratory outcomes. Further study is needed to assess long-term durability and broader applicability.

背景:气管支气管软化症的特征是气道过度动态塌陷,常伴有后膜变宽。我们报告了一种创新的锥形膜缩小气管支气管成形术(TMRT)的结果,该方法旨在缩小后膜并改善功能性气道稳定性。方法:回顾性分析两所医院2022-2024年接受TMRT治疗后膜宽的严重气管支气管软化症患者。在支气管镜引导下,切除后膜纵向条带,同时进行两层纵向闭合。分析患者特征和结果。结果:85例患者(男性65%,食管闭锁66%)接受TMRT治疗,中位年龄为30个月(新生儿-21岁)。常见的适应症包括复发性呼吸道感染(41%),无法脱离正压通气(21%)和蓝色发作(18%)。锥形段为气管(68%)、支气管(5%)和两者(27%)。伴随手术包括后路气管支气管固定术(96%)、后路降主动脉固定术(7%)和食管修复术(35%)。中位随访为22个月(四分位数间距为18-26)。结论:TMRT治疗后膜宽的严重气管支气管软化症是可行和安全的,并且与早期气道功能稳定性和呼吸结局的显著改善有关。需要进一步的研究来评估长期耐久性和更广泛的适用性。
{"title":"Tracheobronchial Membrane Tapering Resection for Tracheobronchomalacia with Wide Posterior Membrane.","authors":"C Jason Smithers, Hester F Shieh, Shawn Izadi, Farokh R Demehri, Somala Mohammed, Russell W Jennings, Benjamin Zendejas","doi":"10.1016/j.athoracsur.2025.12.010","DOIUrl":"https://doi.org/10.1016/j.athoracsur.2025.12.010","url":null,"abstract":"<p><strong>Background: </strong>Tracheobronchomalacia is characterized by excessive dynamic airway collapse, often associated with a wide posterior membrane. We report outcomes of an innovative tapering membrane reduction tracheobronchoplasty (TMRT) designed to narrow the posterior membrane and improve functional airway stability.</p><p><strong>Methods: </strong>Retrospective study of patients who underwent TMRT for severe tracheobronchomalacia with wide posterior membrane from 2022-2024 at two institutions. Under bronchoscopic guidance, a longitudinal strip of posterior membrane was resected with concurrent two-layered longitudinal closure. Patient characteristics and outcomes were analyzed.</p><p><strong>Results: </strong>Eighty-five patients (male 65%; esophageal atresia 66%) underwent TMRT at median age of 30 months (range newborn-21 years). Common indications included recurrent respiratory infections (41%), inability to wean from positive pressure ventilation (21%) and blue spells (18%) . Tapered segment was tracheal (68%), bronchial (5%), and both (27%). Concomitant procedures included posterior tracheobronchopexy (96%), posterior descending aortopexy (7%), and esophageal repair (35%). Median follow was 22 (interquartile range 18-26) months. Significant improvements were seen in blue spells, respiratory infections and ability to wean from ventilation or supplemental oxygen (p<0.05). Complications included esophageal leak (4%), transient vocal fold dysfunction (7%), chylothorax (4%), dysphagia requiring esophageal dilation (8%), and tracheal stenosis requiring dilation (1%). Four patients (5%) required subsequent airway procedures. There were no mortalities.</p><p><strong>Conclusions: </strong>TMRT is feasible and safe for severe tracheobronchomalacia with a wide posterior membrane and is associated with substantial early improvement in functional airway stability and respiratory outcomes. Further study is needed to assess long-term durability and broader applicability.</p>","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145893394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Hidden Burden of Native Aortic Valve Endocarditis: Reevaluating Diagnostic and Pathological Challenges. 原生主动脉瓣心内膜炎的隐性负担:重新评估诊断和病理挑战。
IF 3.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-31 DOI: 10.1016/j.athoracsur.2025.12.007
Ahmed K Awad, James C Witten, Penny Houghtaling, Bo Xu, Tom K Wang, Nabin K Shrestha, Shinya Unai, Eric E Roselli, Gosta B Pettersson, Haytham Elgharably

Background: Native aortic valve endocarditis (NAVE) could present with invasive pathology, which may require complex aortic root reconstruction. Therefore, we aim to examine the incidence of invasive pathology of NAVE, yield of preoperative diagnosis, and surgical approaches in single center experience.

Methods: From 2002 to 2020, 1,488 patients underwent surgery for aortic valve endocarditis at a tertiary institution, including 644 with NAVE. Data was obtained from an institutional Endocarditis Registry database and matching was performed to ensure balanced baseline characteristics.

Results: Among 644 patients with NAVE, 260 (40%) had intra-operative findings of invasive pathology. Staphylococcus aureus was the most common pathogen (26%). Pre-operative echocardiogram detected invasion in only 43% with sensitivity of 52.1% and 35.3% for TEE and TTE, respectively. Computed tomography angiography (CTA) confirmed invasion in 50% (19/38) of echocardiography-positive cases and 22% (9/41) of echocardiography-negative cases with sensitivity of 35.4%. Compared to non-invasive NAVE, invasive NAVE has prolonged CBP times, ventilation, and ICU stay were significantly higher in invasive NAVE (p<0.001, p=0.004, and 0.005, respectively). AVR with an allograft was the most performed surgery for extensive invasive pathology while with patch repair for focal invasion. Survival at 15 years was similar in propensity-matched invasive vs. non-invasive NAVE (40% vs. 39%, p=0.76).

Conclusions: NAVE is not uncommon to present with invasive pathology which could be missed on preoperative imaging. Thus, a high index of suspicion for invasive pathology is advised and preparation for a possible complex operation.

背景:原发性主动脉瓣心内膜炎(NAVE)可表现为侵袭性病理,可能需要复杂的主动脉根重建。因此,我们的目的是在单中心经验下研究NAVE侵袭性病理的发生率、术前诊断的准确率和手术入路。方法:2002年至2020年,1488例在某高等教育机构接受主动脉瓣心内膜炎手术的患者,其中644例为主动脉瓣心内膜炎患者。数据来自机构心内膜炎登记数据库,并进行匹配以确保平衡基线特征。结果:644例NAVE患者中,260例(40%)出现术中浸润性病理表现。金黄色葡萄球菌是最常见的病原体(26%)。术前超声心动图检出率仅为43%,TEE和TTE的敏感性分别为52.1%和35.3%。ct血管造影(CTA)在50%(19/38)超声心动图阳性病例和22%(9/41)超声心动图阴性病例中证实有侵袭,敏感性为35.4%。与非有创性NAVE相比,有创性NAVE的CBP次数、通气时间和ICU住院时间均明显延长(p结论:NAVE表现为侵袭性病理并不罕见,但术前影像学检查可能会遗漏。因此,建议高度怀疑浸润性病理,并为可能的复杂手术做准备。
{"title":"The Hidden Burden of Native Aortic Valve Endocarditis: Reevaluating Diagnostic and Pathological Challenges.","authors":"Ahmed K Awad, James C Witten, Penny Houghtaling, Bo Xu, Tom K Wang, Nabin K Shrestha, Shinya Unai, Eric E Roselli, Gosta B Pettersson, Haytham Elgharably","doi":"10.1016/j.athoracsur.2025.12.007","DOIUrl":"https://doi.org/10.1016/j.athoracsur.2025.12.007","url":null,"abstract":"<p><strong>Background: </strong>Native aortic valve endocarditis (NAVE) could present with invasive pathology, which may require complex aortic root reconstruction. Therefore, we aim to examine the incidence of invasive pathology of NAVE, yield of preoperative diagnosis, and surgical approaches in single center experience.</p><p><strong>Methods: </strong>From 2002 to 2020, 1,488 patients underwent surgery for aortic valve endocarditis at a tertiary institution, including 644 with NAVE. Data was obtained from an institutional Endocarditis Registry database and matching was performed to ensure balanced baseline characteristics.</p><p><strong>Results: </strong>Among 644 patients with NAVE, 260 (40%) had intra-operative findings of invasive pathology. Staphylococcus aureus was the most common pathogen (26%). Pre-operative echocardiogram detected invasion in only 43% with sensitivity of 52.1% and 35.3% for TEE and TTE, respectively. Computed tomography angiography (CTA) confirmed invasion in 50% (19/38) of echocardiography-positive cases and 22% (9/41) of echocardiography-negative cases with sensitivity of 35.4%. Compared to non-invasive NAVE, invasive NAVE has prolonged CBP times, ventilation, and ICU stay were significantly higher in invasive NAVE (p<0.001, p=0.004, and 0.005, respectively). AVR with an allograft was the most performed surgery for extensive invasive pathology while with patch repair for focal invasion. Survival at 15 years was similar in propensity-matched invasive vs. non-invasive NAVE (40% vs. 39%, p=0.76).</p><p><strong>Conclusions: </strong>NAVE is not uncommon to present with invasive pathology which could be missed on preoperative imaging. Thus, a high index of suspicion for invasive pathology is advised and preparation for a possible complex operation.</p>","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145893364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toward Personalized Neoadjuvant Strategies: Using Metabolic and Biological Response to Guide Treatment De-escalation or Intensification. 迈向个性化的新辅助策略:利用代谢和生物学反应来指导治疗的降级或强化。
IF 3.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-30 DOI: 10.1016/j.athoracsur.2025.12.018
Joseph Seitlinger, Bertrand Routy, Moishe Liberman, Jonathan Spicer
{"title":"Toward Personalized Neoadjuvant Strategies: Using Metabolic and Biological Response to Guide Treatment De-escalation or Intensification.","authors":"Joseph Seitlinger, Bertrand Routy, Moishe Liberman, Jonathan Spicer","doi":"10.1016/j.athoracsur.2025.12.018","DOIUrl":"https://doi.org/10.1016/j.athoracsur.2025.12.018","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145890517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
False Lumen Thrombus in Acute Type A Aortic Dissection: Can Volume Fraction Predict Perioperative Risk? 急性A型主动脉夹层假腔血栓:体积分数能否预测围手术期风险?
IF 3.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-30 DOI: 10.1016/j.athoracsur.2025.12.013
Li-Xi Gan, Yi Chang, Hong-Wei Guo
{"title":"False Lumen Thrombus in Acute Type A Aortic Dissection: Can Volume Fraction Predict Perioperative Risk?","authors":"Li-Xi Gan, Yi Chang, Hong-Wei Guo","doi":"10.1016/j.athoracsur.2025.12.013","DOIUrl":"https://doi.org/10.1016/j.athoracsur.2025.12.013","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145890557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Valve-in-chimney technique to surgically solve the problem of extensive mitral annular calcification. 导管内瓣膜技术手术解决广泛二尖瓣环钙化问题。
IF 3.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-30 DOI: 10.1016/j.athoracsur.2025.12.014
Dusko Nezic
{"title":"Valve-in-chimney technique to surgically solve the problem of extensive mitral annular calcification.","authors":"Dusko Nezic","doi":"10.1016/j.athoracsur.2025.12.014","DOIUrl":"10.1016/j.athoracsur.2025.12.014","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145890587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Which life is more important? 哪个生命更重要?
IF 3.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-30 DOI: 10.1016/j.athoracsur.2025.11.043
Marjan Jahangiri
{"title":"Which life is more important?","authors":"Marjan Jahangiri","doi":"10.1016/j.athoracsur.2025.11.043","DOIUrl":"https://doi.org/10.1016/j.athoracsur.2025.11.043","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145890543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Thoracic Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1